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Abstract 1 
Introduction: Acute ischemia due to thrombosed popliteal artery aneurysm (PAA) is 2 
associated with a high risk of limb loss. The aim of this study was to analyze the 3 
outcome, in particular the limb salvage rate in patients undergoing urgent open surgery 4 
for acute ischemia due to thrombosed PAA. 5 
Methods: Retrospective analysis of consecutive patients undergoing urgent open 6 
surgery for acute limb ischemia (Rutherford category ≥ II) due to thrombosed popliteal 7 
artery aneurysm between January 2007 and December 2016 at a tertiary referral center. 8 
Results: Fifty-one patients (92% male) with a median age of 75 years (range 46-97) 9 
were identified. Twenty patients (39%) presented with category IIa acute limb ischemia, 10 
20(39%) with category IIb, and 11(22%) with category III. Four patients (8%) 11 
underwent primary major amputation. Forty-seven (92%) underwent bypass surgery, 12 
43/47(91%) using great saphenous vein. One-vessel runoff was present in 27/47 patients 13 
(57%). Thirty-day mortality was 4% (n=2). Four patients needed major amputation 14 
within 30 days, resulting in an overall 30-day major amputation rate of 16% (8/51, 95% 15 
CI 7.0-28.6). No further major amputations were necessary during a median follow-up 16 
of 41 months (range 4-114) resulting in an estimated four-year limb salvage of 84%. 17 
One-year primary assisted and secondary bypass patency rate was 90% and 95%, 18 
respectively. Estimated four-year primary assisted and secondary patency rate was 82% 19 
and 87%, respectively.  20 
Conclusion: Rapid open surgical revascularization in patients with acute limb ischemia 21 
due to a thrombosed popliteal artery aneurysm results in good long-term limb salvage 22 
rates, especially in Rutherford category IIa and IIb of acute ischemia. Revascularization 23 
may be attempted in clinically severe cases not fulfilling all criteria to be classified as 24 
 3 
category III. Such patients may in fact be borderline between IIb and III. Despite poor 25 
runoff, good bypass patency rates and low rates of claudication can be achieved.  26 
 4 
Introduction 27 
Popliteal artery aneurysms (PAA) are relatively rare with a prevalence of approximately 28 
1% in men aged 65–80 years,1 accounting for more than 80% of all peripheral 29 
aneurysms.2 Acute limb ischemia (ALI) due to aneurysm thrombosis or distal 30 
embolization is the most severe complication of a PAA.3 Revascularization is 31 
challenging and usually performed by open surgery, although a complete endovascular 32 
approach has been reported.4 As crural arteries are often occluded, options for complete 33 
revascularization of the foot are limited possibly resulting in major amputation. 34 
Amputation is associated with worse functional outcome, especially in elderly patients 35 
with cardiovascular comorbidities.5,6 Furthermore, primary amputation offers no cost-36 
benefit compared to bypass surgery when considering the cost of the prosthesis and 37 
rehabilitation.7 Thus, every effort should be taken to achieve limb salvage. The 2017 38 
ESC Guidelines on the management of peripheral artery disease cover ALI, but specific 39 
recommendations regarding PAA are lacking.8 In Rutherford category II urgent 40 
revascularization is indicated. For patients with acute Rutherford category III limb 41 
ischemia, the current recommendation is amputation. There are contemporary series 42 
addressing outcome in ALI due to thrombosed PAA.9,10 These registry papers may 43 
underestimate the amputation rate of thrombosed popliteal artery aneurysms because 44 
they either excluded primary amputations or lack adequate follow-up.9,10 In other 45 
articles reporting the open surgical management of PAA, follow-up of patients 46 
presenting with acute ischemia is poor as well.11 The use of preoperative thrombolysis 47 
in ALI due PAA is controversial and a significant benefit has not been shown in a 48 
recent systematic review.11 We therefore aim to analyze perioperative as well as long-49 
term outcome of patients undergoing urgent open surgery for ALI due to thrombosed 50 
popliteal artery aneurysm, assessing limb salvage and mortality.  51 
 5 
Materials and Methods 52 
This study was approved by the local ethics committee (ID 2017-01529). Consecutive 53 
patients with Rutherford category IIa, IIb, and III ALI due to thrombosed PAA 54 
undergoing urgent surgery between January 2007 and December 2016 were identified 55 
and reviewed retrospectively. Patients with category I ischemia were excluded. 56 
Popliteal artery aneurysm was defined as a popliteal artery diameter of ≥ 13 mm and ≥ 57 
1.5 times the diameter of the upstream and downstream segments measured on 58 
ultrasound or computed tomography (CT) images. The diagnostic algorithm for ALI 59 
and suspected PAA thrombosis included clinical examination and duplex ultrasound. 60 
Preoperative CT angiography was performed at the discretion of the treating vascular 61 
surgeon to assess the extent of thrombosis and potential target vessels. The revised 62 
Rutherford category of acute ischemia12 was preoperatively assessed by the treating 63 
vascular surgeon based on sensorimotor function and Doppler assessment. Of note, 64 
category III is named “irreversible” consisting of major tissue loss or permanent nerve 65 
damage (inevitables), profound sensory loss (anesthetic), profound muscle weakness 66 
(paralysis, rigor), and inaudible arterial and venous Doppler signals. Patients with 67 
Rutherford categories IIa, IIb and III were scheduled for urgent (IIa) or emergent (IIb 68 
and III) surgery. 69 
Operative technique 70 
Intraoperative angiography was performed to assess target vessels. In case of severe 71 
thrombosis without a suitable distal target vessel, all crural vessels were dissected and 72 
selective thrombectomy with or without intra-arterial thrombolysis was performed. 73 
Depending on the surgeon’s preference, between 100’000 and 500’000 IU Urokinase 74 
(Medac GmbH, Wedel, Germany) were delivered into the popliteal or crural arteries. If 75 
 6 
available, the ipsi- or contralateral great saphenous vein was used as a bypass graft. 76 
Arm veins were used as a second choice. If autologous vein material was unavailable, 77 
Omniflow® II (LeMaitre Vascular, Burlington, MA, USA) or ePTFE (BARD Peripheral 78 
Vascular, Temple, AZ, USA) was used. The standard anticoagulation and anti-platelet 79 
regimen consisted of oral anticoagulation with coumadin and acetylsalicylic acid for at 80 
least three months and acetylsalicylic acid alone thereafter. In case of severely 81 
compromised (1-vessel) runoff, lifelong oral anticoagulation was recommended. 82 
Data collection 83 
Preoperative, intraoperative and postoperative data were retrospectively collected from 84 
hospital records. Standard follow-up after bypass surgery included outpatient duplex 85 
ultrasound performed at one and three months. After that, patients were followed every 86 
6-12 months in the outpatient clinic with duplex ultrasound performed at the discretion 87 
of the treating physician, usually in case of claudication or drop in ankle brachial index 88 
(ABI). Follow-up duplex ultrasound reports, ABI measurements, and information on 89 
reinterventions for patients who were followed elsewhere were requested from those 90 
institutions. Vital status or date of death was confirmed by contacting the patients’ 91 
primary care physician or extracted from communal databases. For all patients known to 92 
be alive, a standardized telephone interview was performed at the beginning of March 93 
2017 assessing for claudication or reinterventions at other institutions. Study end date 94 
was defined to be March 6th, 2017. Major amputation was defined as any amputation 95 
above the ankle. Patency was defined and assessed according to Rutherford.12 96 
 97 
 98 
 99 
 7 
Statistical analysis 100 
SPSS Statistics 25.0 (IBM Corp., Armonk, NY, USA) was used for descriptive statistics 101 
and GraphPad Prism 7.00 (GraphPad Software Inc., La Jolla California USA) for 102 
Kaplan-Meier analysis and 95% confidence intervals using the asymmetrical method. 103 
For univariate analysis, we stated proportions, for numerical data mean with standard 104 
deviation (SD) or median with range. Patency rates and amputation-free survival were 105 
estimated using the Kaplan-Meier method. For follow-up patency rates, only patients 106 
with a graft (without in-hospital amputation) were included. Patients known to have 107 
died during follow-up were reported separately with the median time to death. For all 108 
other patients, follow-up completeness was assessed using the Follow-Up Index.13  109 
 8 
Results 110 
Patient characteristics and presentation 111 
Fifty-one patients (92% male) with a median age of 75 years (range 46-97) were 112 
identified. Comorbidities are listed in Table 1. The median size of the PAA was 33 mm 113 
(range 13-80 mm). Six patients (12%) had already undergone open surgery for 114 
contralateral PAA and in an additional 25 patients (49%), contralateral PAA was 115 
detected at presentation or during follow-up. Twenty patients (39%) presented with 116 
Rutherford category IIa acute limb ischemia, 20 patients (39%) with category IIb, and 117 
11 patients (22%) with category III. 118 
Treatment / surgical procedures 119 
Four patients (8%) underwent primary major amputation due to lack of patent outflow 120 
vessels on intraoperative angiography images and severe ischemia (Rutherford category 121 
IIb in one and category III in three patients). In the remaining 47 patients, 122 
revascularization surgery was performed with 44 bypass and 3 interposition grafts. 123 
Great saphenous vein (GSV) was used in 43/47 patients (91%). Other grafts used are 124 
listed in Table 2. The distal target vessel was the below-knee popliteal artery in 26 125 
patients (55%) and the crural arteries in the remaining patients (Table 2). The surgical 126 
approach was medial in 44/47 (94%) and posterior in 3/47 (6%). All bypasses were 127 
routed orthotopically. Intraoperative intra-arterial thrombolysis was used as an adjunct 128 
in 17 patients (36%) with more severe limb ischemia (3 with category IIa, 7 with 129 
category IIb, and 7 with category III; No intraoperative thrombolysis in 17 patients with 130 
category IIa, 13 with category IIb, and 4 with category III, p=0.007). Fasciotomy due to 131 
compartment syndrome was performed in 15/51 patients (29%). Two patients 132 
underwent preoperative local thrombolysis, which is not consistent with our standard 133 
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approach. In these two patients, the diagnosis of PAA had not been established at 134 
admission. Mean length of hospital stay was 14 days (SD 11). 135 
After revascularization, 12 patients (26%) had three-vessel runoff, five patients (11%) 136 
had two-vessel runoff, and 27 patients (57%) had one-vessel runoff, as assessed on 137 
intraoperative angiography. Three patients (6%) had no patent runoff vessel with bypass 138 
outflow to the foot through collaterals only, representing an unsuccessful 139 
revascularization (Figure 1). In these three patients, the bypass target was the below-140 
knee popliteal artery in one and the peroneal artery in two patients. 141 
30-day outcomes 142 
Limb salvage. Four patients needed secondary major amputation within 30 days, 143 
resulting in an overall 30-day major amputation rate of 16% (8/51; 95% CI 7.0-28.6). 144 
Excluding the primary amputations, the 30-day major amputation rate was 9% (4/47). 145 
Two of those undergoing secondary major amputation were patients with collateral 146 
perfusion only and progressive tissue loss despite a patent bypass. The remaining two 147 
patients had one-vessel runoff after initial revascularization; in one the bypass failed 148 
after one day and in the other amputation became necessary due to progressive necrosis 149 
of the foot while the bypass was patent. 150 
The third patient with collateral only flow to the foot, the bypass remained patent but 151 
amputation was recommended due to progression of necrosis. However, the patient 152 
denied amputation and died three months later due to septic complications. 153 
Category IIb and III limb ischemia at presentation was significantly associated with 30-154 
day major amputation (8/31 with category ≥ IIb versus 0/20 with category IIa, p=0.02). 155 
Overall, of eleven patients presenting with category III ischemia, six patients (55%) 156 
underwent primary or secondary amputation and one denied the recommended 157 
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amputation (mentioned above). In the remaining four patients (36%) with category III 158 
ischemia and in 18/20 (90%) with category IIb limb salvage was successful. 159 
Mortality and morbidity. Two patients died within 30 days of surgery, resulting in a 160 
30-day mortality of 4%. One patient died from congestive heart failure due to severe 161 
aortic stenosis after successful limb revascularization and one patient died due to multi-162 
organ failure after denying surgery for complicated diverticulitis after primary 163 
amputation. Non-fatal in-hospital complications included surgical site hematomas (5), 164 
delirium (3), and surgical site bleeding needing reintervention (1), false aneurysm (1), 165 
muscle necrosis of the anterior tibial muscle (1), wound infection (1) and pneumonia 166 
(1), respectively. No patient experienced acute renal failure requiring hemodialysis. 167 
Follow-up 168 
Seventeen patients died during follow-up after a median of 14 months (range 0-93 169 
months, IQR 42 months). Thirty-two patients were alive at the study end date (March 170 
6th, 2017) with a median follow-up of 41 months (range 4-114 months) and a Follow-up 171 
Index of 0.99. 172 
During follow-up, no further major amputations were necessary, resulting in an 173 
estimated four-year limb salvage of 84%. Excluding primary amputations, the estimated 174 
four-year limb salvage was 91%. Of 32 patients alive at the end of follow-up, 28 were 175 
free of major amputation and estimated four-year amputation-free survival was 52% 176 
(Figure 2). Two minor amputations were performed two and four years after initial 177 
revascularization. 178 
Of 28 amputation-free survivors, one patient reported claudication after 500 meters 179 
(Fontaine classification IIa) at the end of follow-up while all other patients were free of 180 
claudication. The four patients with limb salvage in category III ischemia were 181 
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ambulating without complains after revascularization but three died during follow-up 182 
after a median of 1.9 years (median age at presentation 89 years); one was alive and free 183 
of claudication at the study end date (3.5 years after revascularization). 184 
Graft patency. Estimated 1-year primary assisted and secondary patency rate was 90% 185 
and 95%, respectively. Estimated 4-year primary assisted and secondary patency rate 186 
was 82% and 87%, respectively (Figure 3). 187 
Re-interventions. Three re-interventions were performed for primary assisted patency: 188 
an anastomotic stenosis was treated with a stent in two patients and with an open patch 189 
plasty in one patient. Seven patients had bypass occlusion after a median of 36 months 190 
(range 0-97) after initial revascularization. In four patients, a bypass thrombectomy was 191 
performed. In three of those, a focal stenosis was identified as the cause of bypass 192 
occlusion and was treated with patch plasty. Three patients underwent a redo bypass 193 
procedure after failed bypass salvage and of these, two underwent a second redo bypass 194 
procedure and additional endovascular interventions due to repeated bypass failure.  195 
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Discussion 196 
In this single-center retrospective series, we report the outcome of 51 patients with 197 
acute limb ischemia due to a thrombosed popliteal aneurysm. Revascularization in this 198 
setting remains a surgical challenge since runoff is usually poor and patients may be 199 
admitted with considerable time delay. Patients with popliteal artery aneurysms may 200 
have multiple silent and time-shifted thromboembolic events before presenting with 201 
acute ischemia due to complete aneurysm thrombosis.14,15 This results in very poor 202 
outflow complicating revascularization. In our series, 57% of the patients had one-203 
vessel runoff, and 6% had no patent vessel in the lower leg. Similarly, Lilly and 204 
colleagues described decades ago that arterial anatomy below popliteal aneurysms is 205 
distinctly abnormal in 90% of the cases with 86% of patients with severe ischemia 206 
having only single-vessel runoff.15 207 
Thirty-day major amputation rate in our series was 16% (95% CI 7.0-28.6) with four 208 
patients undergoing primary amputation and four patients undergoing secondary 209 
amputation after attempted revascularization. As no further major amputations were 210 
necessary during follow-up, four-year estimated limb salvage rate was 84%. A 211 
multicentric Italian study from 2013 reported a two-year limb salvage rate of ALI due to 212 
PAA treated surgically of 81.5% (41 patients).16 Similarly, a systematic review by 213 
Kropman et al. reported a five-year limb salvage rate of 74%.17 A Swedvasc report 214 
showed a similar one year amputation rate of 13.4% (including primary amputation), 215 
but the follow up at one year was only 87% and the patient cohort was markedly 216 
different (13.2% category I patients).9 217 
A Vascunet report with data from eight countries, excluding primary amputations, 218 
showed a discharge / 30-day amputation rate of 6.5%.10 However, category of ischemia 219 
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is not reported. Excluding primary amputations in our series, the one-year amputation 220 
rate was 9%. 221 
Estimated four-year primary assisted and secondary patency rates in our series were 222 
82% and 87% respectively. This is in line with Kropman’s findings of a five-year 223 
secondary patency of 80%.17 In our series 96% of patients without major amputation 224 
denied any claudication symptoms at follow-up, which is also satisfactory, considering 225 
the high prevalence of outflow vessel obstruction in these patients. 226 
Clinical assessment and categorization according to Rutherford et al. is crucial when 227 
reporting acute limb ischemia. Eleven patients were preoperatively classified as 228 
category III. This would actually deem their ischemia irreversible leading to 229 
amputation.8,12 As four patients were salvageable in our series we must, retrospectively, 230 
assume that these cases were initially misclassified and did not show all the 231 
characteristics described by Rutherford et al. and therefore were severe category IIb 232 
patients. Only the postoperative course may have definitely showed that these cases 233 
were only mimicking category III, and were therefore salvageable. However, if no 234 
runoff can be achieved intraoperatively by means of thrombectomy and thrombolysis, 235 
placement of a bypass seems not advisable.  236 
Preoperative thrombolysis has extensively been discussed for ALI due to thrombosed 237 
PAA.18 A recent systematic review could not show significant reduction of amputations 238 
after preoperative thrombolysis. Five-year primary patency rates, secondary patency and 239 
limb salvage rates were not different after thrombolysis when compared to patients who 240 
did not undergo thrombolysis.17 Many open surgical series included in this review had 241 
low patient numbers and acute ischemia was classified only in 122 of 895 patients.17 In 242 
other series investigating this issue, data on the severity of ischemia is lacking.3 243 
Neurologic deficits (Rutherford category IIb and III) are well-known indications for 244 
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emergent revascularization.12 Preoperative thrombolysis may only lead to a better 245 
outcome in patients with less severe ischemia who per se have better outcomes 246 
regarding limb salvage. We only included patients with limb-threatening ischemia 247 
(Rutherford category ≥ II) in our series. These patients should be treated immediately 248 
because of the considerable threat of permanent neuromuscular and tissue damage.8 249 
Preoperative thrombolysis may lead to a delay in open surgical revascularization.12 Our 250 
data does not add knowledge to the topic of preoperative thrombolyis, since it was only 251 
performed in two cases. 252 
Open bypass surgery is the standard treatment for ALI due to thrombosed PAA at our 253 
institution. A complete endovascular approach has been reported in the literature. The 254 
largest series by Fargion and colleagues included six patients.4 One patient died shortly 255 
after early stent thrombosis and major amputation. The remaining five patients showed 256 
a primary patency rate of 60% and a secondary patency rate of 80% after a mean 257 
follow-up of 28.6 months. The authors state that this approach is an alternative in 258 
selected high-risk patients with specific anatomic requirements, but should not replace 259 
GSV bypass as the gold standard.4 260 
Another important issue is the association of PAA with other aneurysms, especially 261 
contralateral PAA or AAA.11 Sixty-one percent of patients in our series had 262 
contralateral PAA. Six patients had already undergone open surgery for contralateral 263 
PAA when presenting with acute limb ischemia due to PAA thrombosis on the other 264 
side. Median time from previous PAA surgery to contralateral PAA thrombosis was 265 
nine years. This emphasizes the importance of life-long follow-up in these patients, not 266 
only to assess bypass patency after PAA repair but for surveillance of aneurysmal 267 
disease of the contralateral leg and other associated aneurysms. In an elective setting, 268 
PAA can be treated with a low morbidity and mortality and excellent long-term 269 
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outcomes which are far superior to the results in acute ischemia.11,19 Therefore, we aim 270 
to search for PAA in patients with known aneurysms at other sites and operate them 271 
electively at a diameter of 20mm. 272 
Limitations. As this is a retrospective single-center study, certain factors may limit the 273 
generalizability of the study results. The limited number of patients is reflected by the 274 
broad 95% CI in our results. A future large multicentric collaboration could allow for 275 
analyses of subgroups to provide more insight concerning the best treatment option for 276 
each patient. The category of acute ischemia was documented by the treating vascular 277 
surgeon. We assume misclassification for some category III patients, since they were 278 
not all amputated. Because this is a retrospective analysis we cannot perform a detailed 279 
clinical re-assessment of these cases and had to rely on the clinician’s evaluation 280 
provided back then. However, publications in this field suffer from this particular bias 281 
as well, e.g. some do not report the category of ischemia of the patients included. 282 
There is no comparator group, since all patients were treated by open surgery. The 283 
selection of graft material, surgical technique, the use of thrombolysis and the 284 
anticoagulation and anti-platelet regimen were at the discretion of the vascular surgeon 285 
who operated and therefore not standardized. Although regular follow-up visits in our 286 
outpatient clinic were documented in most patients, some were followed at other 287 
institutions and therefore clinical and ultrasound follow-up was not standardized. Thus, 288 
asymptomatic bypass occlusion might not have been detected in some patients. Causes 289 
of death are not known in most of the diseased patients. Furthermore, over the span of 290 
ten years substantial improvements in interdisciplinary treatment have been achieved. 291 
This might have led to less time to intervention and hence higher limb salvage rates. 292 
Due to the small study population, we did not analyze trends over time. The time from 293 
symptom onset until revascularization is an important issue in ALI. Most of the patients 294 
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had gradually worsening symptoms and were not able to report a precise time of 295 
symptom onset. A strength of the present study is the defined study end date with 296 
almost complete follow-up (Follow-Up Index 0.99) and standardized telephone 297 
interviews with all surviving patients at the end of follow-up.  298 
 299 
Conclusion. Rapid open surgical revascularization in patients with acute limb ischemia 300 
due to thrombosed popliteal artery aneurysm results in good long-term limb salvage 301 
rates in our series, especially in Rutherford category IIa and IIb of acute ischemia. 302 
Revascularization may be attempted in clinically severe cases not fulfilling all criteria to 303 
be classified as category III. Such patients may in fact be borderline between IIb and III. 304 
Despite poor runoff, good bypass patency rates and low rates of claudication can be 305 
achieved.  306 
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What this study adds to the current evidence 307 
This study represents a single-center series of open surgical management of acute 308 
presentations of thrombosed popliteal artery aneurysm. It stands out from other 309 
contemporary reports due to inclusion of patients with severe ischemia and a complete 310 
follow-up (median 41 months, Follow-up Index 0.99). Rapid open surgical 311 
revascularization without preoperative thrombolysis can lead to good rates of limb 312 
salvage and bypass patency despite poor runoff. 313 
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Tables 390 
Table 1 391 
Demographic data  
Number of patients, n (%) 51 (100%) 
Age (years), median (range) 75 (46-97) 
Male, n (%) 47 (92%) 
Comorbidities, n (%)  
Coronary artery disease 22/51 (43%) 
Previous vascular surgery 11/51 (22%) 
Hypertension 40/51 (78%) 
Diabetes 8/51 (16%) 
Dyslipidemia 27/51 (53%) 
Smoking 31/51 (61%) 
GFR ≤60ml/min 5/51 (10%) 
COPD 3/51 (6%) 
  392 
 22 
Table 2 393 
Parameter Proportion % 
Rutherford classification of acute ischemia at presentation   
IIa 20/51 39 
IIb 20/51 39 
III 11/51 22 
Existing contralateral PAA 31/51 61 
Previous surgery 6/31 19 
Intra-arterial thrombolysis  
Preoperative 
Intraoperative 
 
2/51 
17/51 
 
4 
33 
Type of surgery   
Primary amputation  4/51 8 
Bypass / interposition graft 47/51 92 
GSV 43/47 91 
Omniflow 2/47 4 
Omniflow with cephalic vein 1/47 2 
PTFE with GSV 1/47 2 
Approach   
Medial 44/47 94 
Dorsal 3/47 6 
Target vessel   
Below-knee popliteal artery 26/47 55 
Anterior tibial artery 2/47 4 
Tibioperoneal trunk 5/47 11 
Posterior tibial artery 
Peroneal artery 
Combined 
4/47 
6/47 
4/47 
9 
13 
9 
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Figure and Table Legends 395 
Table 1. Demographic data and comorbidities (Abbreviations: GFR = glomerular 396 
filtration rate, COPD = chronic obstructive pulmonary disease) 397 
Table 2. Clinical presentation and surgical data (Abbreviations: GSV = great saphenous 398 
vein, PTFE = Polytetrafluoroethylene) 399 
Figure 1: Distribution of patent crural vessel after revascularization. 400 
Figure 2: Kaplan-Meier estimate of amputation-free survival including 95% confidence 401 
intervals (dotted lines). 402 
Figure 3: Kaplan-Meier estimates of primary assisted and secondary patency rates. 403 
